Major Medical Journal Retracts Study on Immune Cell Treatment for Severe Lung Disease

A prominent respiratory medicine journal has retracted a 2015 study claiming that infusing patients' own immune cells could treat severe acute respiratory distress syndrome. The retraction signals concerns about the study's validity and underscores ongoing quality-control challenges in medical research that can mislead hospitals and pharmaceutical developers.

Originaltitel: Autologous Peripheral Blood Mononuclear Cells as Treatment in Refractory Acute Respiratory Distress Syndrome (Retraction of Vol 90, Pg 481, 2015)